Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2026-02-01 @ 6:05 AM
Study NCT ID:
NCT01589159
Status:
COMPLETED
Last Update Posted:
2017-02-27
First Post:
2012-04-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes
Sponsor:
Organization: